Kallol Ray Chaudhuri Selected Research

Kallol Ray Chaudhuri Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 07/2022 - 11/2010
7	Pain (Aches) 01/2021 - 03/2014
3	Fatigue 01/2018 - 11/2010
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 09/2016 - 06/2015
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 09/2015
1	Severe Acute Respiratory Syndrome 07/2022
1	Periodontitis 04/2022
1	Dyskinesias (Dyskinesia) 07/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Dementia (Dementias) 01/2018
1	Orthostatic Hypotension (Postural Hypotension) 09/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2015
1	Sleep Apnea Syndromes (Sleep Apnea) 09/2015
1	Anhedonia 06/2015
1	Hallucinations (Hallucination) 01/2011
1	Illusions (Auditory Illusions) 01/2011
1	Nocturia 01/2011
1	Hyperhidrosis 01/2011
1	Dizziness (Lightheadedness) 01/2011
1	Nausea 01/2011
1	Sleep Wake Disorders 06/2010
1	Parkinsonian Disorders (Parkinsonism) 06/2010
1	Disorders of Excessive Somnolence (Hypersomnia) 06/2010
1	Narcolepsy 06/2010
1	Muscle Cramp (Cramp) 02/2008
1	Restless Legs Syndrome (Restless Legs) 02/2008

Drug/Important Bio-Agent (IBA)

4	Levodopa (L Dopa)FDA LinkGeneric 07/2021 - 12/2015
4	Pharmaceutical PreparationsIBA 01/2018 - 01/2014
3	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 11/2010
3	Dopamine (Intropin)FDA LinkGeneric 09/2016 - 11/2010
3	Dopamine Agonists (Dopamine Agonist)IBA 07/2015 - 02/2008
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2019
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 02/2008
2	pimavanserinIBA 01/2018 - 09/2015
2	ropinirole (Requip)FDA LinkGeneric 06/2015 - 02/2008
2	Pramipexole (Mirapex)FDA LinkGeneric 06/2015 - 02/2008
2	rotigotine FDA Link 03/2014 - 01/2011
1	AngiotensinsIBA 07/2022
1	C-Reactive ProteinIBA 04/2022
1	Carbidopa (Lodosyn)FDA LinkGeneric 07/2021
1	propylene diquat (PDQ(+))IBA 01/2021
1	catechol (pyrocatechol)IBA 10/2018
1	opicaponeIBA 10/2018
1	TransferasesIBA 10/2018
1	safinamideIBA 10/2018
1	Monoamine Oxidase (MAO)IBA 10/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2015
1	Rivastigmine (Exelon)FDA LinkGeneric 09/2015
1	Solifenacin Succinate FDA Link 09/2015
1	Doxepin (Mareen)FDA LinkGeneric 09/2015
1	Piribedil (Trivastal)IBA 09/2015
1	DroxidopaIBA 09/2015
1	Opiate AlkaloidsIBA 09/2015
1	Cabergoline FDA LinkGeneric 06/2015
1	amsonic acid (DAS)IBA 06/2015
1	Apomorphine FDA Link 01/2011
1	benzylamineIBA 11/2010
1	Dihydroxyphenylalanine (Dopa)IBA 11/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2010
1	OrexinsIBA 06/2010

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2011
3	Deep Brain Stimulation 07/2021 - 09/2015
1	Activities of Daily Living (ADL) 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Denervation 12/2015
1	Continuous Positive Airway Pressure 09/2015
1	Subcutaneous Infusions 01/2011